
Global Cord Blood Corporation – NYSE:CO
Global Cord Blood stock price today
Global Cord Blood stock price monthly change
Global Cord Blood stock price quarterly change
Global Cord Blood stock price yearly change
Global Cord Blood key metrics
Market Cap | 400.08M |
Enterprise value | N/A |
P/E | 5.06 |
EV/Sales | -5.06 |
EV/EBITDA | -10.02 |
Price/Sales | 1.91 |
Price/Book | 0.48 |
PEG ratio | -3.58 |
EPS | 4.13 |
Revenue | 1.24B |
EBITDA | 637.79M |
Income | 502.43M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 40.3% |
Oper. margin | 48.97% |
Gross margin | 85.26% |
EBIT margin | 48.97% |
EBITDA margin | 51.3% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGlobal Cord Blood stock price history
Global Cord Blood stock forecast
Global Cord Blood financial statements
Jun 2021 | 315.17M | 136.42M | 43.28% |
---|---|---|---|
Sep 2021 | 313.67M | 125.73M | 40.09% |
Dec 2021 | 317.20M | 135.55M | 42.74% |
Mar 2022 | 297.20M | 104.71M | 35.23% |
Payout ratio | 0% |
---|
2013 | |
---|---|
2017 | |
2019 | 0.3% |
2020 | |
2022 |
Sep 2021 | 8258258000 | 3.60B | 43.65% |
---|---|---|---|
Dec 2021 | 8397726000 | 3.61B | 42.99% |
Mar 2022 | 8534525000 | 3.64B | 42.76% |
Jul 2022 | 1346288000 | 575.70M | 42.76% |
Jun 2011 | 0 | 0 | 0 |
---|---|---|---|
Sep 2011 | 0 | 0 | 0 |
Dec 2011 | 0 | 0 | 0 |
Mar 2022 | 162.03M | -6.25M | 0 |
Global Cord Blood alternative data
Aug 2023 | 1,202 |
---|---|
Sep 2023 | 1,202 |
Oct 2023 | 1,202 |
Nov 2023 | 1,202 |
Dec 2023 | 1,202 |
Jan 2024 | 1,202 |
Feb 2024 | 1,202 |
Mar 2024 | 1,202 |
Apr 2024 | 1,202 |
May 2024 | 1,202 |
Jun 2024 | 1,202 |
Jul 2024 | 1,202 |
Global Cord Blood other data
Period | Buy | Sel |
---|---|---|
May 2014 | 109000 | 0 |
Jun 2014 | 127000 | 0 |
Jul 2014 | 50000 | 0 |
Sep 2014 | 43705 | 0 |
Nov 2014 | 266754 | 0 |
Dec 2014 | 730000 | 0 |
Jan 2015 | 310000 | 0 |
Quarter | Transcript |
---|---|
Q3 2022 1 Mar 2022 | Q3 2022 Earnings Call Transcript |
Q2 2022 26 Nov 2021 | Q2 2022 Earnings Call Transcript |
Q4 2021 29 Jun 2021 | Q4 2021 Earnings Call Transcript |
Q2 2021 25 Nov 2020 | Q2 2021 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Bing Chuen Chen (1976) Chief Financial Officer & Director | $516,680 |
Ms. Ting Zheng (1972) Chairperson , Chief Executive Officer & Chief Executive Officer of Beijing Division | $516,680 |
Ms. Rui Arashiyama (1959) Chief Executive Officer of Guangdong & Zhejiang Divisions | $257,500 |
Ms. Xin Xu (1954) Chief Technology Officer | $122,780 |
Pounce On Global Cord For The Year Of The Tiger
Global Cord Blood: With 6.0x P/E And 24% EPS CAGR, Subscriber Growth Continues
Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes
Global Cord Blood: New China Policy Catalyst, 146% Net Cash And 24% EPS CAGR
-
What's the price of Global Cord Blood stock today?
One share of Global Cord Blood stock can currently be purchased for approximately $2.99.
-
When is Global Cord Blood's next earnings date?
Unfortunately, Global Cord Blood's (CO) next earnings date is currently unknown.
-
Does Global Cord Blood pay dividends?
No, Global Cord Blood does not pay dividends.
-
How much money does Global Cord Blood make?
Global Cord Blood has a market capitalization of 400.08M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.21% to 1.24B US dollars.
-
What is Global Cord Blood's stock symbol?
Global Cord Blood Corporation is traded on the NYSE under the ticker symbol "CO".
-
What is Global Cord Blood's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Global Cord Blood?
Shares of Global Cord Blood can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Global Cord Blood's key executives?
Global Cord Blood's management team includes the following people:
- Mr. Bing Chuen Chen Chief Financial Officer & Director(age: 49, pay: $516,680)
- Ms. Ting Zheng Chairperson , Chief Executive Officer & Chief Executive Officer of Beijing Division(age: 53, pay: $516,680)
- Ms. Rui Arashiyama Chief Executive Officer of Guangdong & Zhejiang Divisions(age: 66, pay: $257,500)
- Ms. Xin Xu Chief Technology Officer(age: 71, pay: $122,780)
-
How many employees does Global Cord Blood have?
As Jul 2024, Global Cord Blood employs 1,202 workers.
-
When Global Cord Blood went public?
Global Cord Blood Corporation is publicly traded company for more then 18 years since IPO on 25 Jan 2007.
-
What is Global Cord Blood's official website?
The official website for Global Cord Blood is globalcordbloodcorp.com.
-
How can i contact Global Cord Blood?
Global Cord Blood can be reached via phone at +852 3605 8180.
Global Cord Blood company profile:

Global Cord Blood Corporation
globalcordbloodcorp.comNYSE
1,202
Medical - Diagnostics & Research
Healthcare
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Central,
CIK: 0001467808
ISIN: KYG393421030
CUSIP: G39342103